- Conditions
- Functional Constipation (FC), Chronic Idiopathic Constipation (CIC)
- Interventions
- Placebo for Linaclotide, Linaclotide
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 2 Years to 5 Years
- Enrollment
- 123 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 38
- States / cities
- Foley, Alabama • Phoenix, Arizona • Hot Springs, Arkansas + 33 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–6
of 6
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Functional Constipation
- Interventions
- Linaclotide, Placebo
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 6 Months to 23 Months
- Enrollment
- 19 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 18
- States / cities
- Phoenix, Arizona • Hot Springs, Arkansas • Anaheim, California + 14 more
- Conditions
- Chronic Constipation, Functional Constipation
- Interventions
- Placebo Capsule, YKP10811 Drug Product Capsule
- Drug
- Lead sponsor
- SK Life Science, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 57 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Functional Constipation in Children Ages 6-17 Years
- Interventions
- Placebo, LIN Dose A, LIN Dose B, LIN Dose C, LIN 145 µg
- Drug
- Lead sponsor
- Forest Laboratories
- Industry
- Eligibility
- 6 Years to 17 Years
- Enrollment
- 173 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 60
- States / cities
- Hot Springs, Arkansas • Little Rock, Arkansas • Anaheim, California + 51 more
- Conditions
- Irritable Bowel Syndrome With Constipation, Functional Constipation
- Interventions
- Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 and LIN-MD-64 completers), Functional Constipation (FC) participants (LIN-MD-62 and LIN-MD-64 completers)
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 6 Years to 18 Years
- Enrollment
- 381 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2025
- U.S. locations
- 65
- States / cities
- Birmingham, Alabama • Foley, Alabama • Saraland, Alabama + 50 more
- Conditions
- Functional Constipation, Irritable Bowel Syndrome With Constipation
- Interventions
- Linaclotide, Placebo
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 6 Years to 17 Years
- Enrollment
- 438 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 79
- States / cities
- Birmingham, Alabama • Foley, Alabama • Saraland, Alabama + 62 more